Several nanomedicines have been approved by the EMA, showcasing the potential of nanotechnology in medicine. Examples include:
Doxil: A liposomal formulation of doxorubicin used for the treatment of various cancers. Abraxane: A nanoparticle albumin-bound formulation of paclitaxel used for the treatment of breast cancer and other cancers. Onivyde: A liposomal irinotecan formulation used for the treatment of pancreatic cancer.
